Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1937 1
1938 1
1951 1
1953 3
1954 1
1963 1
1966 1
1969 1
1976 1
1978 1
1979 2
1984 1
1985 1
1987 1
1989 5
1990 4
1991 1
1992 2
1993 1
1994 11
1995 9
1996 4
1997 3
1998 6
1999 4
2000 7
2001 4
2002 3
2003 6
2004 5
2005 4
2006 10
2007 2
2008 12
2009 19
2010 22
2011 25
2012 19
2013 23
2014 29
2015 27
2016 28
2017 30
2018 33
2019 31
2020 42
2021 31
2022 46
2023 31
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

505 results

Results by year

Filters applied: . Clear all
Page 1
Sickle cell disease.
Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Ware RE, et al. Among authors: abboud mr. Lancet. 2017 Jul 15;390(10091):311-323. doi: 10.1016/S0140-6736(17)30193-9. Epub 2017 Feb 1. Lancet. 2017. PMID: 28159390 Review.
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J; HOPE Trial Investigators. Vichinsky E, et al. Among authors: abboud mr. N Engl J Med. 2019 Aug 8;381(6):509-519. doi: 10.1056/NEJMoa1903212. Epub 2019 Jun 14. N Engl J Med. 2019. PMID: 31199090 Clinical Trial.
Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY).
Osunkwo I, Andemariam B, Minniti CP, Inusa BPD, El Rassi F, Francis-Gibson B, Nero A, Trimnell C, Abboud MR, Arlet JB, Colombatti R, de Montalembert M, Jain S, Jastaniah W, Nur E, Pita M, DeBonnett L, Ramscar N, Bailey T, Rajkovic-Hooley O, James J. Osunkwo I, et al. Among authors: abboud mr. Am J Hematol. 2021 Apr 1;96(4):404-417. doi: 10.1002/ajh.26063. Epub 2021 Feb 25. Am J Hematol. 2021. PMID: 33264445 Free PMC article.
Hemoglobinopathies (Sickle Cell Disease and Thalassemia).
Cappelli B, Gluckman E, Ghanem K, Abboud MR. Cappelli B, et al. Among authors: abboud mr. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition. Cham (CH): Springer; 2019. Chapter 79. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition. Cham (CH): Springer; 2019. Chapter 79. PMID: 32091749 Free Books & Documents. Review.
A Diverse View of Science to Catalyse Change.
Urbina-Blanco CA, Jilani SZ, Speight IR, Bojdys MJ, Friščić T, Stoddart JF, Nelson TL, Mack J, Robinson RAS, Waddell EA, Lutkenhaus JL, Godfrey M, Abboud MI, Aderinto SO, Aderohunmu D, Bibič L, Borges J, Dong VM, Ferrins L, Fung FM, John T, Lim FPL, Masters SL, Mambwe D, Thordarson P, Titirici MM, Tormet-González GD, Unterlass MM, Wadle A, Yam VW, Yang YW. Urbina-Blanco CA, et al. Among authors: abboud mi. J Am Chem Soc. 2020 Aug 26;142(34):14393-14396. doi: 10.1021/jacs.0c07877. Epub 2020 Aug 17. J Am Chem Soc. 2020. PMID: 32803980 No abstract available.
Standard management of sickle cell disease complications.
Abboud MR. Abboud MR. Hematol Oncol Stem Cell Ther. 2020 Jun;13(2):85-90. doi: 10.1016/j.hemonc.2019.12.007. Epub 2020 Mar 12. Hematol Oncol Stem Cell Ther. 2020. PMID: 32202245 Free article. Review.
Electrolyte Imbalance in Anti-LGI1 Encephalitis: It Is Not All in Your Head.
Gadoth A, Nisnboym M, Alcalay Y, Zubkov A, Schwartz I, Schwartz D, Abboud M, Rubinek T, Yossepowitch O, Weinstein T. Gadoth A, et al. Among authors: abboud m. Neurol Neuroimmunol Neuroinflamm. 2023 Aug 17;10(6):e200155. doi: 10.1212/NXI.0000000000200155. Print 2023 Nov. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37591767 Free article. Review.
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.
Piel FB, Rees DC, DeBaun MR, Nnodu O, Ranque B, Thompson AA, Ware RE, Abboud MR, Abraham A, Ambrose EE, Andemariam B, Colah R, Colombatti R, Conran N, Costa FF, Cronin RM, de Montalembert M, Elion J, Esrick E, Greenway AL, Idris IM, Issom DZ, Jain D, Jordan LC, Kaplan ZS, King AA, Lloyd-Puryear M, Oppong SA, Sharma A, Sung L, Tshilolo L, Wilkie DJ, Ohene-Frempong K. Piel FB, et al. Among authors: abboud mr. Lancet Haematol. 2023 Aug;10(8):e633-e686. doi: 10.1016/S2352-3026(23)00096-0. Epub 2023 Jul 11. Lancet Haematol. 2023. PMID: 37451304 Review. No abstract available.
505 results